VKH
ORKA

Virtu KCG Holdings’s Oruka Therapeutics ORKA Stock Holding History

Virtu KCG Holdings’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-73
Closed -$54K – 3395
2016
Q1 		$54K Buy
73
+6
+9% +$4.88K ﹤0.01% 2448
2015
Q4 		$68K Buy
67
+20
+43% +$22.6K ﹤0.01% 3094
2015
Q3 		$51K Buy
+47
New +$71.6K ﹤0.01% 2994
2015
Q2 		– Sell
-53
Closed -$63K – 3831
2015
Q1 		$63K Sell
53
-15
-22% -$17.6K ﹤0.01% 2775
2014
Q4 		$97K Buy
68
+52
+325% +$78.3K ﹤0.01% 3233
2014
Q3 		$29K Sell
16
-16
-50% -$33.4K ﹤0.01% 3432
2014
Q2 		$71K Sell
32
-16
-33% -$37.2K ﹤0.01% 3367
2014
Q1 		$133K Buy
+48
New +$140K ﹤0.01% 3128

Other funds holding ORKA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Virtu KCG Holdings's ORKA Position: Q2 2016 in Review

Virtu KCG Holdings sold out of Oruka Therapeutics (ORKA) in Q2 2016, closing a stake of 73 shares — an estimated $54K sold.

Virtu KCG Holdings first reported a position in ORKA in Q1 2014 and held it in 8 quarters. The position peaked at $133K in Q1 2014. 21 funds tracked by Wall St. Rank hold ORKA as of Q2 2016.

  • Virtu KCG Holdings reported no remaining Oruka Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 73 Oruka Therapeutics shares in Q2 2016, an estimated $54K.
  • Virtu KCG Holdings first reported a position in Oruka Therapeutics in Q1 2014 and held it in 8 quarters.
  • Virtu KCG Holdings's Oruka Therapeutics position peaked at $133K in Q1 2014.
  • 21 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2016.

Based on Virtu KCG Holdings's 13F filing for Q2 2016, filed 12 Aug 2016.